AstraZeneca Pharma India Limited ASTRAZEN.NS · Stock Open AstraZeneca Pharma India Limited in new tab
AstraZeneca Pharma India Limited Analysis (ASTRAZEN.NS)
Is AstraZeneca Pharma India Limited a good investment? AstraZeneca Pharma India Limited (ASTRAZEN.NS) is currently trading at 8242.00 INR.
In terms of valuation, the stock trades at a P/E ratio of 110.31. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: AstraZeneca Pharma India Limited is expected to release its next earnings report on May 28, 2026.
For income investors, AstraZeneca Pharma India Limited pays a dividend yield of 0.39%. With a payout ratio of 43%, the dividend appears sustainable.
Investor FAQ
Does AstraZeneca Pharma India Limited pay a dividend?
Yes, it pays an annual dividend of 32.00 INR (0.39% yield).
What asset class is AstraZeneca Pharma India Limited?
AstraZeneca Pharma India Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be May 28, 2026. The company currently has a trailing EPS of 75.00.
Company Profile
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company has a strategic collaboration with Leica Biosystems and Daiichi Sankyo Company, Limited for the development of an immunohistochemistry assay and an image analysis algorithm for the TROP2 NMR biomarker in non-small cell lung cancer. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
| Year | Total Dividends |
|---|---|
| ▸2026 |
48.00 INR
|
| Sept. 7, 2026 (estimated) | 48.0000 |
| ▸2025 |
32.00 INR
|
| Sept. 2, 2025 | 32.0000 |
| ▸2024 |
24.00 INR
|
| Sept. 6, 2024 | 24.0000 |
| ▸2023 |
16.00 INR
|
| Sept. 13, 2023 | 16.0000 |
| ▸2022 |
8.00 INR
|
| Sept. 6, 2022 | 8.0000 |
| ▸2021 |
2.00 INR
|
| Sept. 7, 2021 | 2.0000 |
| ▸2020 |
2.00 INR
|
| Sept. 8, 2020 | 2.0000 |
| ▸2019 |
1.00 INR
|
| Sept. 4, 2019 | 1.0000 |
| ▸2012 |
3.50 INR
|
| Aug. 17, 2012 | 3.5000 |
| ▸2011 |
10.00 INR
|
| July 28, 2011 | 10.0000 |
| ▸2010 |
10.00 INR
|
| June 19, 2010 | 10.0000 |
| ▸2009 |
15.00 INR
|
| June 1, 2009 | 15.0000 |
| ▸2008 |
15.00 INR
|
| May 1, 2008 | 15.0000 |
| ▸2007 |
24.00 INR
|
| April 25, 2007 | 12.0000 |
| April 1, 2007 | 12.0000 |
| ▸2006 |
20.00 INR
|
| April 29, 2006 | 20.0000 |
| ▸2005 |
50.00 INR
|
| April 6, 2005 | 50.0000 |
| ▸2004 |
3.90 INR
|
| May 5, 2004 | 3.9000 |
| ▸2003 |
3.70 INR
|
| May 7, 2003 | 3.7000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| AstraZeneca Pharma India Limited | Sep 02, 2025 | Paid | 32.0 INR |
| Split Date | Split Ratio to 1 |
|---|---|
| June 15, 2006 | 5.000000 |
Community Discussion